Amylin: difference between revisions
Diff·revision 4 → 5·07:46, 30 Sep 2024
Difference between revision 4 and revision 5 of Amylin. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 4 — 14:25, 19 Sep 2024 SarcopeniaSefa (talk) add the year of first marketing authorisation, with the regulator named 1,974 bytes +705 | Revision 5 — 07:46, 30 Sep 2024 SemaglutideSasha (talk) split §Pharmacology into receptor binding and downstream signalling 1,974 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |